Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P M Carvey

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
Neurology|May 1, 1993
Blood levodopa levels and unified Parkinson's disease rating scale function: with and without exerciseC G Goetz, J A Thelen, C M MacLeod, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 1, 1997
The stability of carbidopa in solutionE J Pappert, J W Lipton, C G Goetz, et al.
Pediatric Research|September 1, 1993
Effect of cocaine in early gestation on striatal dopamine and neurotrophic activityD E Weese-Mayer, J M Silvestri, D Lin, et al.
Journal of Neurosurgery|January 1, 1991
Dopamine distribution and behavioral alterations resulting from dopamine infusion into the brain of the lesioned ratJ S Kroin, L C Kao, T J Zhang, et al.
Experimental Neurology|May 19, 2001
Tumor necrosis factor alpha is toxic to embryonic mesencephalic dopamine neuronsS O McGuire, Z D Ling, J W Lipton, et al.
Neurology|January 28, 1999
Animal model of posthypoxic myoclonus: effects of serotonergic antagonistsE J Pappert, C G Goetz, T Q Vu, et al.
Neurology|July 1, 1988
Controlled-release carbidopa/levodopa (CR4-Sinemet) in Parkinson's disease patients with and without motor fluctuationsC G Goetz, C M Tanner, K M Shannon, et al.
Experimental Neurology|August 25, 2001
A clonal line of mesencephalic progenitor cells converted to dopamine neurons by hematopoietic cytokines: a source of cells for transplantation in Parkinson's diseaseP M Carvey, Z D Ling, C E Sortwell, et al.
Pharmacology, Biochemistry, and Behavior|September 1, 1993
Alterations in striatal neurotrophic activity induced by dopaminergic drugsP M Carvey, L R Ptak, D Lin, et al.
Neurology|May 1, 1991
The potential use of a dopamine neuron antibody and a striatal-derived neurotrophic factor as diagnostic markers in Parkinson's diseaseP M Carvey, A McRae, T F Lint, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Neurology|May 1, 1993
Blood levodopa levels and unified Parkinson's disease rating scale function: with and without exerciseC G Goetz, J A Thelen, C M MacLeod, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 1, 1997
The stability of carbidopa in solutionE J Pappert, J W Lipton, C G Goetz, et al.
Pediatric Research|September 1, 1993
Effect of cocaine in early gestation on striatal dopamine and neurotrophic activityD E Weese-Mayer, J M Silvestri, D Lin, et al.
Journal of Neurosurgery|January 1, 1991
Dopamine distribution and behavioral alterations resulting from dopamine infusion into the brain of the lesioned ratJ S Kroin, L C Kao, T J Zhang, et al.
Experimental Neurology|May 19, 2001
Tumor necrosis factor alpha is toxic to embryonic mesencephalic dopamine neuronsS O McGuire, Z D Ling, J W Lipton, et al.
Neurology|January 28, 1999
Animal model of posthypoxic myoclonus: effects of serotonergic antagonistsE J Pappert, C G Goetz, T Q Vu, et al.
Neurology|July 1, 1988
Controlled-release carbidopa/levodopa (CR4-Sinemet) in Parkinson's disease patients with and without motor fluctuationsC G Goetz, C M Tanner, K M Shannon, et al.
Experimental Neurology|August 25, 2001
A clonal line of mesencephalic progenitor cells converted to dopamine neurons by hematopoietic cytokines: a source of cells for transplantation in Parkinson's diseaseP M Carvey, Z D Ling, C E Sortwell, et al.
Pharmacology, Biochemistry, and Behavior|September 1, 1993
Alterations in striatal neurotrophic activity induced by dopaminergic drugsP M Carvey, L R Ptak, D Lin, et al.
Neurology|May 1, 1991
The potential use of a dopamine neuron antibody and a striatal-derived neurotrophic factor as diagnostic markers in Parkinson's diseaseP M Carvey, A McRae, T F Lint, et al.
Pageof 7